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S U M M A R Y
Objectives: To investigate the genes of antibiotic resistance among isolates from the ﬁrst reported
carbapenem-resistant Klebsiella pneumoniae (CRKP) outbreak in a tertiary care hospital, Riyadh, Saudi Arabia.
Methods: Antimicrobial susceptibility testing was performed on bacterial isolates using the Microscan
Walkaway system (Siemens, Germany) and was conﬁrmed by Etest (AB Biodisk, Sweden). bla-CTX-M, -SHV,
-TEM, -OXA-48, OXA-A,B,C,D, -KPC, -NDM, -VIM, -IMP, integron 1, and outer membrane proteins(Omp)-35 and Omp-
36 were investigated by PCR ampliﬁcation and direct sequencing of PCR products. Isolates were
sequence-typed by multilocus sequence typing (MLST).
Results: All isolates were resistant to cefotaxime, ceftazidime, cefepime, ciproﬂoxacin, and piperacillin–
tazobactam, and 91% (21 out of 23) were resistant to amikacin and gentamicin. All isolates except two
from a single patient were resistant to one of the carbapenems. CTX-M and SHV genes were detected in
all isolates, CTX-M-15 and SHV-1 types being predominant among these extended-spectrum beta-
lactamases (ESBLs). TEM-1 was found in all except one isolate (isolate 3). Signiﬁcantly, the OXA-48 gene
was also found in all isolates. OXA-D-gene was found in three out of 23 isolates. KPC, NDM, OXA-A, -B, -C,
VIM, and IMP genes were absent in all isolates. Disruption of the Omp-36 gene due to insertion of
transposon IS903 and/or IS4 was detected in four out of 23 isolates, and some unique variations were also
observed in this gene, including an insertion of two amino acids in the L3 region of Omp-36 in one isolate
(isolate 3) and a mutation resulting in a premature stop codon in another isolate (isolate 25). MLST
revealed ST29 to be the predominant sequence type (17 out of 23 isolates, 74%). Three were ST709 and
one each was ST37 and ST111; one isolate had an unknown ST.
Conclusions: This is probably the ﬁrst reported outbreak of multidrug/carbapenem-resistant Klebsiella
infection involving the OXA-48 gene from Saudi Arabia. Although the presence of ESBLs such as OXA,
CTX-M, TEM, and SHV are predictable reasons for resistance, variations in the Omp-36 gene might also
have precipitated this phenomenon. Disruption of the Omp-36 sequence by large insertional elements,
the insertion of two amino acids in a very crucial part of this protein, and the presence of a premature
stop codon in one isolate might have rendered this protein incomplete and non-functional. The study
also demonstrated that more than one type of clone was responsible for this reported apparent outbreak
and that ST29, a clone not reported from this region before, was the major clone responsible.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Klebsiella pneumoniae is a pathogen of the Enterobacteriaceae
family that causes healthcare-associated infections and has
recently emerged as one of the most antibiotic-resistant organisms
responsible for outbreaks in the healthcare setting.1,2 Although
Enterobacteriaceae members are known to produce the conven-
tional extended-spectrum beta-lactamases (ESBLs) conferring
resistance to different types of antibiotics, carbapenem resistance
was previously uncommon in K. pneumoniae isolates.3 However, a
signiﬁcant number of emerging reports suggest that the suscepti-
bility to carbapenem of these bacteria is no longer guaranteed.4
Resistance to carbapenem in these organisms is on the increase
and this poses a signiﬁcant threat in the management of
multidrug-resistant isolates.5
Carbapenem resistance can arise through the acquisition of
resistance genes encoding metallo-beta-lactamases, non-metallo-
carbapenemases (KPC, GES, or OXA-type), AmpC, or ESBLs and an
alteration in the expression of the outer membrane protein
(OMP).6–8 Resolution of the three-dimensional structure of the
Escherichia coli OmpF and K. pneumoniae OmpC-like porin
(OmpK36) has led to the identiﬁcation of the functional domains
of the channels.9 Recent studies have identiﬁed amino acids
important in porin structure and function in bacteria.10 The
replacement of these amino acids by mutation may greatly
decrease diffusion through the porin in some clinical strains.11 The
mutations detected in L5, L6, and in the strategic L3 have been
implicated in marked resistance to cephalosporins and impaired
cephalosporin uptake associated with a decrease in ion conduc-
tance (De E et al., 2001). The involvement of porin loss in
combination with the conventional ESBL genes and KPC in a
carbapenem-resistant K. pneumoniae outbreak has recently been
reported from a Chinese hospital.12 Here we report our ﬁndings on
the occurrence of newly described OXA-48, the distribution of
different ESBLs, and some unique variations in Omp-36 in isolates
from an outbreak of carbapenem-resistant K. pneumoniae infection
at King Abdulaziz Medical City, a tertiary care hospital in Riyadh,
Saudi Arabia.
2. Methods
Isolates saved from the 2010 outbreak were identiﬁed by the
hospital microbiology laboratory, as detailed in our previous
report.13 During this period, a total number of 23 isolates were
collected from 22 patients in different wards. Routine microbio-
logical investigations including minimum inhibitory concentration
(MIC) determinations were carried out. These isolates were stored
in trypticase soy broth (TSB) with 20% glycerol at 70 8C and
revived on sheep blood agar plates; they were then transferred toTable 1
List of primers used in this study for various gene targets
Gene target Forward primer (50 to 30) 
KPC GATACCACGTTCCGTCTGG 
VIM TTTGGTCGCATATCGCAACG 
IMP GTTTATGTTCATACATCG 
OXA-48 TTGGTGGCATCGATTATCGG 
OMP-35 CAGACACCAAACTCTCATCAAGGG 
OMP-36 CAGCACAATGAATATAGCCGAC 
OMP-36 N CTGCGGCTGACCTGTCGCTGAAC 
SHV ATGCGTTATATTCGCCTGT 
TEM AAACGCTGGTGAAAGTA 
CTX-M TTTGCGATGTGCAGTACCAGTAA 
PER ATGAATGTCATTATAAAAG 
INTEGRON-1 TCATGGCTTGTTATGACTGT TSB and incubated overnight at room temperature at the time of
use for further studies.
2.1. Antibiotic susceptibility tests
Isolates were identiﬁed using the standard laboratory methods
of the Clinical and Laboratory Standards Institute (CLSI) guide-
lines.14 Identiﬁcation of K. pneumoniae to the species level was
done using the Microscan Walkaway system (Siemens, Germany)
and then conﬁrmed using the API20E Bacterial Identiﬁcation
System (bioMe´rieux, USA). Antimicrobial susceptibility testing
was determined using the Microscan Walkaway system and
conﬁrmed using the Etest (AB Biodisk, Sweden). MIC breakpoints
for carbapenems (meropenem and/or imipenem) were deﬁned
according to the 2010 CLSI guidelines.15 K. pneumoniae isolates
found to have elevated MICs for carbapenem were tested for the
presence of carbapenemases using the modiﬁed Hodge test16 as
part of our investigation into the outbreak; details are given in our
previous publication.13
2.2. Multilocus sequence typing (MLST)
MLST was done on these isolates using the protocol of
Diancourt et al.17 Brieﬂy, the seven conserved housekeeping
genes, namely rpoB, gapA, mdh, pgi, phoE, infB, and tonB, were PCR
ampliﬁed and sequenced. The sequences were submitted to the
KP-MLST database (http://www.pasteur.fr/recherche/genopole/
PF8/mlst/primers_Kpneumoniae.html) for analysis and sequence
type (ST) designation.
2.3. ESBLs and other related genes
The primers used for PCR ampliﬁcation for ESBLs and other
related genes and their subsequent sequencing are listed in
Table 1. A uniplex PCR was run for all genes under study. All results
are based on a positive PCR ampliﬁcation and subsequent
sequencing of each gene, at least in duplicate, for all of the
isolates. A PCR was considered negative after failure to amplify the
target of expected size at least three times. Internal primers were
designed and utilized to fully characterize the insertion elements
detected in some of the isolates and for full-length sequencing of
Omp. The amplicons of positive reactions were puriﬁed using
MinElute PCR/Gel puriﬁcation columns (Qiagen). Sequencing was
performed in both directions on an ABI-3100 DNA Analyzer. The
sequences were analyzed using the SeqMan (Lasergene 6) software
tool. Variation in any nucleotide was taken into consideration only
when it was observed in sequences of both directions. Sequences
thus obtained were submitted to BLAST for determination of
identities in the GenBank sequence database of the National CenterReverse primer (50 to 30) Reference
GCAGGTTCCGGTTTTGTCTC Hindiyeh et al.34
CCATTCAGCCAGATCGGGCAT Hujer et al.35
GGTTTAACAAAACAACCAC Hujer et al.35
GAGCACTTCTTTTGTGATGGC Poirel et al.36
AGAATTGGTAAACGATACCCACG Kaczmarek et al.25
GCTGTTGTCGTCCAGCAGGTTG Kaczmarek et al.25
CGGTCAGCTGGTCGTTGATCTGG This study
TGCTTTGTTATTCGGGCCAA Hujer et al.35
AGCGATCTGTCTAT Paterson et al.37
CGATATCGTTGGTGGTGCCATA Edelstein et al.38
TTGGGCTTAGGGCAG Hujer et al.35
GTAGGGCTTATTATGCACGC Hujer et al.35
Table 2
Minimum inhibitory concentrations (mg/ml) of antimicrobial agents tested for the outbreak isolates of Klebsiella pneumoniae
Isolate No. Cefotaxime Ceftazidime Cefepime Gentamicin Amikacin Ciproﬂoxacin TMP–SMX Meropenem Ertapenem Imipenem TZP
1 >16 >32 64 64 96 6 32 4 16 6 256
2 >16 >32 256 1 256 >32 >32 >32 >32 >32 256
3 64 256 16 0.25 48 256 0.064 5 32 12 256
4 256 256 256 32 64 256 32 32 32 32 256
5 >16 >32 256 128 256 >32 32 >32 >32 >32 256
6 256 256 256 8 64 32 2 32 32 32 256
7 >16 >32 256 32 64 >32 >32 >32 >32 >32 256
8 256 256 256 6 32 32 0.5 6 32 8 256
9 256 256 256 32 4 8 32 8 32 24 256
12 256 64 192 256 128 32 32 0.64 0.64 0.125 32
13 256 64 192 256 128 32 32 0.64 0.64 0.125 32
14 256 >32 16 24 32 32 >32 3 4 0.75 256
16 256 192 256 16 32 12 3 16 32 32 256
17 256 128 48 8 16 16 0.19 4 16 4 256
18 >16 >32 256 64 96 4 >32 4 >32 1.5 256
19 256 96 64 16 32 32 32 3 4 4 256
20 256 128 32 24 64 6 32 1.5 6 1 256
21 256 16 24 24 32 4 32 4 8 0.5 256
22 256 256 256 4 2 32 32 32 32 32 256
23 N/A N/A 256 256 128 32 N/A 8 N/A 8 N/A
24 256 192 256 64 256 32 32 32 32 32 256
25 256 128 256 48 128 16 32 32 32 32 256
26 256 192 256 32 256 32 32 4 4 4 256
TMP–SMX, trimethoprim–sulfamethoxazole; TZP, piperacillin–tazobactam; N/A, Not Available.
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sequences for OMPs were aligned against the reference sequences
using BioEdit sequence alignment software. Phylogenic and
molecular evolutionary analysis was conducted implementing
the Kimura 2-parameter model using MEGA version 4.18
3. Results
3.1. MICs
The MIC results for the isolates are given in Table 2. As per the
criterion for a multidrug-resistant organism (MDRO), all isolates
were resistant to three or more types of antibiotics. All isolatesTable 3
ESBLs and other genes in isolates from the reported outbreak
Isolate No. MLST Index date OXA-48 OXA- D TEM-1 SHV
1 29 Mar 24, 2010 Pos Neg Pos Pos
2 37 Mar 5, 2010 Pos Neg Pos Neg
3 111 Aug 21, 2010 Pos Neg Neg Neg
4 29 Mar 31, 2010 Pos Neg Pos Pos
5 29 Mar 28, 2010 Pos Neg Pos Pos
6 709 Jul 7, 2010 Pos Pos Pos Neg
7 29 April 6, 2010 Pos Neg Pos Pos
8 709 Aug 22, 2010 Pos Pos Pos Neg
9 29 May 8, 2010 Pos Neg Pos Pos
12 29 Dec 1, 2009 Pos Neg Pos Pos
13 29 Dec 1, 2009 Pos Neg Pos Pos
14 29 Mar 27, 2010 Pos Neg Pos Pos
16 29 Jul 22, 2010 Pos Neg Pos Pos
17 29 Jul 15, 2010 Pos Neg Pos Pos
18 29 Feb 14, 2010 Pos Neg Pos Pos
19 UKa Mar 6, 2010 Pos Neg Pos Neg
20 29 Feb 26, 2010 Pos Neg Pos Pos
21 29 Mar 3, 2010 Pos Neg Pos Pos
22 709 Mar 13, 2010 Pos Pos Pos Neg
23 29 Mar 9, 2010 Pos Neg Pos Pos
24 29 Jun 16, 2010 Pos Neg Pos Pos
25 29 Apr 12, 2010 Pos Neg Pos Pos
26 29 Jul 18, 2010 Pos Neg Pos Pos
MLST, multilocus sequence typing; UK, unknown; Pos, Positive; Neg, Negative.
a Nearest match is ST111.were resistant to cefotaxime, ceftazidime, cefepime, ciproﬂoxacin,
and piperacillin–tazobactam, whereas 91% (21 out of 23) were
resistant to amikacin and gentamicin. Two isolates from a single
patient were sensitive to carbapenems but resistant to the rest of
the antibiotics.
3.2. MLST
The MLST results showed four sequence types (STs) to be
involved in this outbreak. Out of 23 isolates, 17 were ST29. Isolates
6, 8, and 22 belonged to ST709. Isolate 3 was ST111, whereas
isolate 2 was ST37. The ST for isolate 19 did not match any of the
types in the database, however ST111 was the nearest match.-1 SHV-11 SHV-12 CTX-M-14 CTX-M-15 Class 1 integron
 Neg Neg Neg Pos aadB
 Pos Neg Neg Pos aadB, dfrA7
 Pos Neg Neg Pos aadB, dfrA17
 Neg Neg Neg Pos aadB
 Neg Neg Neg Pos aadB
 Neg Pos Neg Pos -
 Neg Neg Neg Pos aadB
 Neg Pos Pos Neg -
 Neg Neg Neg Pos aadB
 Neg Neg Neg Pos aadB, dfrA7
 Neg Neg Pos Neg aadB
 Neg Neg Neg Pos aadB
 Neg Neg Neg Pos -
 Neg Neg Neg Pos -
 Neg Neg Neg Pos -
 Pos Neg Neg Pos aadB
 Neg Neg Neg Pos -
 Neg Neg Neg Pos dfrA7
 Neg Pos Pos Neg aadB
 Neg Neg Neg Pos aadB
 Neg Neg Neg Pos aadB
 Neg Neg Neg Pos aadB
 Neg Neg Neg Pos aadB
Figure 1. PCR ampliﬁcation of the Omp-36 gene in Klebsiella isolates. Upper row: M, 100-bp marker; lanes 1–9 are isolates 1–9; lanes 10–12 are isolates 12–14; lanes 13–19
are isolates 16–22. Lower row: M, 100-bp marker; lanes 1–4 are isolates 23–26; lanes 5–8 are positive control strains of Klebsiella; lane 9 is empty; lane 10 is the negative
control. Lanes 4, 5, 7, and 12 of the upper gel and lane 2 of the lower gel show an insert in this gene.
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The results of the antibiotic resistance genes are given in
Table 3. OXA-48 was present in all isolates. OXA-D-type geneFigure 2. Omp-36 protein sequence alignment for Klebsiella isolates with some known 
presented. A sequence from GenBank (Z33506) was used as the reference sequence.was found in three isolates. CTX-M and SHV genes were also
found in all isolates, CTX-M-15 and SHV-1 being predominant
among these ESBLs (87% and 74%, respectively). TEM-1 was
found in all except one isolate (isolate 3). Class 1 integron wassequences. Only those parts that showed a substitution, insertion, or a deletion are
T. uz Zaman et al. / International Journal of Infectious Diseases 28 (2014) 186–192190positive in 74% of isolates and aadB was predominant. None of
the isolates was positive for OXA-A, -B, -C, KPC, NDM, VIM, or
IMP.
3.4. Outer membrane protein sequence analysis
A normal Omp-35 sequence was observed in all isolates.
However, large numbers of variations were found in the Omp-36
gene sequence. Four isolates (4, 5, 7, and 14) had an amplicon
larger than the expected size (approximately 1.1 kb) for Omp-36
(Figure 1). Upon sequencing, these isolates were found to have an
insertion of transposon IS903 at nucleotide 127 of their Omp-36
gene. Isolates 4 and 5 had an insert of 1069 bp, whereas the size of
the insert in isolates 7 and 14 was about 1220 bp, with a difference
of 163 bp. Of these 163 nucleotides, 127 were a repeat sequence of
the beginning of Omp-36, whereas the remaining 36 nucleotides
were from IS4 insertion element. The 19 remaining isolates with no
insert also showed a large number of variations in their Omp-36
gene. These variations included additions, deletions, and substitu-
tions when compared to wild-type K. pneumoniae strain ATC 13883
(accession number Z33506). These variations are shown in
Figure 2. A phylogenetic relationship based on Omp-36 sequence
similarity of these isolates with the known sequences is depicted in
Figure 3.
4. Discussion
Many of the carbapenem-resistant Enterobacteriaceae out-
breaks identiﬁed have been related to the production of
carbapenemases, speciﬁcally KPC-1 and -3, as well as theFigure 3. Phylogeny of isolates from this study based on Omp-36 sequence similarities. 
matching with FJ577674.metallo-beta-lactamases VIM and IMP.19 However, resistance to
carbapenem is not restricted to the above and may involve other
mechanisms, including structural changes in the outer membrane
and hyper production of AmpC, in addition to ESBL or carbape-
nemase production.1,19,20 The observation of the newly described
OXA-48 in all K. pneumoniae isolates in our study is signiﬁcant. This
is probably the ﬁrst report of a carbapenem-resistant K.
pneumoniae outbreak in a hospital setting in Saudi Arabia involving
OXA-48, acknowledging the recent ﬁndings of Mathers et al. in a
patient who had travelled from Riyadh, Saudi Arabia and was
reported to be infected by K. pneumoniae with OXA-48.21 This may
suggest a more serious endemicity of this gene among K.
pneumoniae isolates from the hospital setting in the Kingdom or
even the Gulf countries, and is worthy of further epidemiological
studies.
The high incidence (87%) of isolates with co-expression of OXA-
48 and CTX-M-15 found in this study has also been reported widely
from other parts of the world.5,22,23 The presence of CTX-M-15 and
SHV-12 as predominant ESBLs in K. pneumoniae isolates in this
study is consistent with the ﬁndings of another recently reported
study from this region.24 There also appears to be a correlation
between the sequence type and an ESBL genotype, particularly the
bla-SHV and bla-CTX-M subtypes. Among non-ESBL SHVs, SHV-1
was found in isolates with ST29 and SHV-11 in those with ST111/
37, whereas ESBL-positive SHV (SHV-12) was seen in isolates with
ST709. However, this could be due simply to the clustering of
isolates in an apparent outbreak. The CTX-M-15 gene was found in
the majority of isolates (20 out of 23 isolates; 86.9%) regardless of
the sequence type, whereas two out of three isolates exhibiting
CTX-M-14b were ST709.These isolates are clustered in three clusters, the largest comprising 14 isolates and
T. uz Zaman et al. / International Journal of Infectious Diseases 28 (2014) 186–192 191The expression of Omp-36 has been shown to be a major factor
in conferring resistance against carbapenems in K. pneumoniae.7
The disruption of Omp-36 by virtue of insertional elements (IS903
and IS4), as seen in isolates 4, 5, 7, and 14 from our outbreak, has
been reported previously in carbapenem-resistant K. pneumoniae
isolates from Westchester Medical Center, NY25 and Taiwan.26 The
G!T mutation observed in isolate 25 at nucleotide position
259 generates a TAA stop codon in the sequence, thus resulting in
an incomplete or non-functional OMP protein. The unique
variations observed in the cluster comprising 13 isolates
(Figure 2) had not been described previously in a K. pneumoniae
strain with known biological properties. The hot spot for variations
in these isolates is in the region of L2 and in the L4–L5 regions
(Figure 2). It has been reported that L2 has an afﬁnity to bind with
imipenem and a deletion in this region has resulted in much lower
afﬁnity to imipenem.27 A crucial variation in the L3 region in
isolate 3 was observed in the form of insertion of serine and glycine
residues in the highly conserved motif PEFGGD (Figure 2); this has
not been reported previously, although the addition of two
different amino acids (phenylalanine and glycine) was observed
in a Klebsiella strain NVT2001, serotype 2 isolated from a patient
with liver abscess in Taiwan.28 A mutation of G!D at L3 and
variations in other regions including L4 and L5 of Omp-36 have
widely been shown to cause major functional changes in the
bacterial porin function, including a decrease in carbapenem and
cephalosporin diffusion through it.11,29–31 Functional studies are
needed to conﬁrm the effects of these variations; however, it has
been shown that there could be an interplay between different
mechanisms to achieve carbapenem resistance.32
The sequence typing by MLST on these isolates showed that the
largest group (17 out of 23) involved in this outbreak belonged to
ST29, a genotype not reported from this region before. The other
STs involved were ST709 with three isolates and ST111 with two
isolates. An allelic difference was observed at locus InfB due to a
single nucleotide variation in one of these two ST111 isolates.
ST111 was reported in a human patient from Spain in 1993 and
was subsequently repeatedly isolated from bovine origin samples
in the USA.33 The much more common sequence type ST37 was
found in only one patient.
In conclusion, this report presents an outbreak of multidrug/
carbapenem-resistant K. pneumoniae carrying OXA-48 in combi-
nation of CTX-M-15. To our knowledge no outbreak involving OXA-
48 has been reported from Saudi Arabia before. It also appears that
the outer membrane porin Omp-36 plays a contributing role in
antibiotic resistance. ST29, the major clone responsible for the
present outbreak, is new to this region and requires further
investigation.
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